Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

BPY2 Inhibitors

BPY2 inhibitors are a class of chemical compounds designed to specifically target and inhibit the BPY2 (Basic Protein, Y-linked 2) protein, a member of the Y chromosome-encoded gene family involved in spermatogenesis. BPY2 is expressed predominantly in the testes and plays a crucial role in sperm development and maturation, particularly in the regulation of the protein synthesis and cellular processes necessary for normal sperm function. BPY2 inhibitors have been developed to study the molecular mechanisms through which BPY2 contributes to these processes, allowing researchers to gain insight into its precise biological functions and regulatory mechanisms.

BPY2 inhibitors are small molecules engineered to interact with critical regions of the BPY2 protein, such as its active or binding sites. By inhibiting BPY2's activity, these molecules can disrupt its interaction with other proteins or cellular structures involved in sperm development. The chemical makeup of BPY2 inhibitors often features moieties that enable selective binding to the BPY2 protein, ensuring targeted disruption without affecting other proteins in the cellular environment. This specificity allows scientists to investigate how the inhibition of BPY2 impacts sperm formation and maturation, leading to a deeper understanding of the molecular pathways regulated by BPY2. Through the use of these inhibitors, researchers can explore BPY2's role in male reproductive biology and its broader contribution to cellular processes related to protein regulation in spermatogenesis.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Levonorgestrel

797-63-7sc-205731
sc-205731A
100 mg
500 mg
$43.00
$194.00
1
(0)

Levonorgestrel affects hormonal regulation and could indirectly lead to reduced BPY2 expression in testicular cells.

Tamoxifen

10540-29-1sc-208414
2.5 g
$256.00
18
(2)

Tamoxifen acts as an estrogen receptor modulator, which might indirectly modify BPY2 expression via hormonal pathways.